X Factors

We are all in the business of improving the quality of human lives.

Each of us, whether client or provider, are joined in the commitment to reach critical milestones faster, to deliver clinical materials on time, to control costs and above all to ensure quality.

At Xcelience, we call this Molecular Responsibility™ – the commitment to hold ourselves to ever increasing high standards of quality, service performance, and drug and pharmaceutical development development expertise that in turn enables our clients to overcome drug development and preformulation challenges and improve the chances of compound success.

Since 1997, Xcelience has been renowned for reliably expediting drug product development and clinical manufacturing for solid, semi-solid and oral liquid dosage forms. Our formulation development scientists have considerable experience overcoming challenges associated with physical and chemical properties of drug substance, or limited quantities of active pharmaceutical ingredient (API), in a manner that results in compounds with improved solubility and bioavailability.

Xcelience operates out of a cGMP compliant, FDA audited, DEA licensed facility in Tampa, Florida. Our recently expanded process technology capabilities reflect our continued commitment to help clients build towards improved drug manufacturing outcomes in a manner consistent with the FDA’s Quality by Design initiative.

To learn more about how we can help build success into your drug product, simply click the Get A Solution tab at the top of this page or call Randall H. Guthrie, Vice President at 1-608-643-4444.